1Garratt CJ,Hind ID,Haddock RE.Single/repeat dose kinetics ofsibutramine metabolites in obeses subjects (abstract)[].Journal of Clinical Pharmacology.1995
2Drouin P,Hanotin C,Courciers,et al.A dose-ranging study efficacy andtolerability of sibutramine in weight loss[].Int J Ohes.1994
3Study number SB 1049,Federal Drug Administration New Drug Approvalpackge [on-line]. http://w.w.w.fda gov cder /foi /ida /index 97 htm . 1998
4.Meridia (sibutramine hydrolride monohydrate)Product information knollpharmaceutical conpany[]..1997
5Bach DS,Rissanen AM,Mendel CM et.al.Absence of cardiac valvedysfunction in obese patients treated with sibutrsmine[].International Journal of Obesity.1998
7Bray,G.A.,Ryan,D.H.,Gordon,D.A double-blind randomized placebo-controlled trial of sibutramine[].Obesity Research.1996
8Garratt CJ,Hind ID,Haddock RE.Single/repeat dose kinetics ofsibutramine metabolites in obeses subjects(abstract)[].Journal of Clinical Pharmacology.1995
9Luscombe GP,Hopcroft RH,Thomas PC,et al.The contribution ofmetabolites to the rapid and potent down-regulation of rat conical betaadrenoceptors by the putative antidepressant sibutramine hydrochloride[].Neuropharmacology.1989
10Weintraub M.Rubio A,Golik A,et.al .Sibutramine in weight control: adose-ranging,efficacy study[].Clinical Pharmacology and Therapeutics.1991
4Victorzon M, Tolonen P. Laparoscopic silicone adjustable gastric band: initial experience in Finland[J]. Obes Surg, 2000, 10:369-371.
5Edward H. Livingston, MD. Obesity and its surgical management [J]. The American Journal of Surgery, 2002, 184: 103-113.
6Papasavas PK, Hayetian FD, et al. Outcome analysis of laparoscopic Roux-en-Y gastric bypass for morbid obesity[J]. The first 116 cases. Surg Endosc, 2002, 16(12): 1653-1657.
